Search Results - "Kisliakova, T V"

The influence of mesenchymal stem cell transplantation time on myocardial reparation in rat experimental heart failure by Krugliakov, P V, Sokolova, I B, Amineva, Kh K, Nekrasova, N N, Viĭde, S V, Cherednichenko, N V, Zaritskiĭ, A Iu, Semerin, E N, Kisliakova, T V, Polyntsev, D G

“…Mesenchymal stem cells (MSCs) have an ability to migrate in the organism to injured tissue to exert influence on inflammation and reparation in these regions…”
Get more information

The influence of mesenchymal stem cells on bone tissue regeneration upon implantation of demineralized bone matrix by Krugliakov, P V, Sokolova, I B, Zin'kova, N N, Viĭde, S V, Cherednichenko, N N, Kisliakova, T V, Polyntsev, D G

“…Mesenchymal stem cells (MSC) are resident pluripotent cells of bone marrow stroma. MSC are able to differentiate into chondroblasts, adipocytes, neurons, glia,…”
Get more information

Combined surgical and immunotherapeutic treatment of patients with fourth stage colon cancer by Tarasov, V A, Filatov, M V, Kisliakova, T V, Noskov, F S, Koloskov, A V, Stavrovietski, V V, Onikienko, S B, Kletchikov, V Z, Lvov, I V, Yu Varfolomeeva, E, Blizniukov, O P, Levina, V V, Kiselevski, M V

“…Sixty-five patients with the fourth stage colon cancer were subjected to the combined surgical and immunotherapy. The following conclusions are made: (1)…”
Get more information

Mesenchymal stem cells-based therapy of brain ischemic stroke in rat by Zin'kova, N N, Gilerovich, E G, Sokolova, I B, Viĭde, S K, Shvedova, E V, Aleksandrov, G V, Krugliakov, P V, Kisliakova, T V, Polyntsev, D G

“…Mesenchymal stem cells (MSCs)-based therapy is a promising modern attempt to improve the recovery after stroke. Experiments were carried out on inbred…”
Get more information

G1 block of the cell cycle during differentiation of F9 cells correlates with accumulation of inhibitors of the activity of cyclin-kinase complexes of proteins p21/Waf1 and p27/Kip by Malashicheva, A B, Kisliakova, T V, Pospelov, V A

“…F9 teratocarcinoma cells have a very short duration of the cell cycle with a short G1-period typical for early embryonic cells. The cells are capable of…”
Get more information

A new human cellular protein AUP1. I. In vitro interaction of AUP1 with adenoviral proteins E4ORF3 and E1A by Karpisheva, K V, Tauber, B, Kisliakova, T V, Dobner, T

“…The 11-kDa product of adenovirus early region 4 (E4) open reading frame (ORF) 3 participates in many processes occurring in infected cell, including…”
Get more information

A new human cellular protein AUP1. III. The intracellular localization of AUP1 protein in different human and rat cell lines by Karpisheva, K V, Tauber, B, Kisliakova, T V, Dobner, T

“…Previously, we cloned a full-length cDNA of human Aup1 and showed that AUP1 may represent a new cellular target for the two adenovirus oncoproteins, E1A Ad5…”
Get more information

A new human cellular protein AUP1. II. cDNA cloning, genomic organization of Aup1 gene ans preliminary characterization of human AUP1 protein by Karpisheva, K V, Touber, B, Kisliakova, T V, Dobner, T

“…We report here the cloning of human cDNA of Aup1 gene (ancient uniquitous protein 1), its genomic organization and preliminary characterization of human AUP1…”
Get more information

The lack of G1/S arrest of teratocarcinoma F9 cells is determinated by degradation of cyclin-dependent kinases inhibitor p21waf1/cip1 by Malashicheva, A B, Kisliakova, T V, Pospelov, V A

“…We have studied the ability of F9 teratocarcinoma cells to arrest in G1/S and G2/M checkpoints following gamma-irradiation. Wild-type p53 protein is rapidly…”
Get more information

Differentiated murine F9 teratocarcinoma cells are susceptible to apoptosis upon contact with substrate by Lianguzova, M S, Pospelov, V A, Kisliakova, T V

“…Epithelial and endothelial cells are susceptible to a subset of apoptosis known as anoikis. This type of programmed cell death is activated upon disruption of…”
Get more information

Embryonal stem cells do not undergo cell cycle arrest upon exposure to damaging factors by Malashicheva, A B, Kisliakova, T V, Savatier, P, Pospelov, V A

“…As shown recently (Malashicheva et al., 2000), embryonic teratocarcinoma F9 mouse cells do not stop on the G1/S border after the treatment with agents causing…”
Get more information

Mesenchymal stem cell transplantation for myocardial reparation of rat experimental heart failure by Krugliakov, P V, Sokolova, I B, Amineva, Kh K, Nekrasova, N N, Viĭde, S V, Cherednichenko, N N, Zaritskiĭ, A Iu, Semernin, E N, Kisliakova, T V, Polyntsev, D G

“…Mesenchymal stem cells (MSC) are resident pluripotent cells of bone marrow stroma. MSC have the ability to differentiate into osteoblasts, chondroblasts and…”
Get more information

Apoptotic cell death of F9 mouse embryonal teratocarcinoma depends on cell population density by Malashicheva, A B, Kisliakova, T V, Pospelov, V A

“…Apoptosis, or programmed cell death, is an active process fundamental to the development and homeostasis of multicellular organisms. Mouse embryonal carcinoma…”
Get more information

Noninduced single-stranded breaks in DNA in murine F9 teratocarcinoma cells by Kisliakova, T V, Kustova, M E, Lianguzova, M S, Malashcheva, A B, Strunnikova, M A, Suchkova, I O, Pospelov, V A, Patkin, E L

“…Our previous study demonstrated the high incidence of non-induced DNA single strand breaks (SSB) in preimplantation mouse embryo genom (Patkin et al., 1994)…”
Get more information

The use of B1-PCR method for studying the genomic polymorphism involved in malignant growth by Aleksandrova, S A, Ermilov, A N, Kisliakova, T V, Artsybasheva, I V, Shvemberger, I N

“…The BI-PCT method showed the profile of BI-associated fragments of LNA in the cell line of the mouse hepatoma MH-22a to differ from that of the liver cells of…”
Get more information

The growth and morphological characteristics of undifferentiated and differentiated cells of the F9 mouse teratocarcinoma line by Kisliakova, T V, Pospelova, T V, Pospelov, V A

“…Differentiation of the F9 cell line was induced by treating the cells with retinoic acid (10(-6) M) and dibutyryl cycloadenosinemonophosphate (10(-4) M). The…”
Get more information

The c-fos proto-oncogene promotor is not regulated by serum, epidermal growth factor, and phorbol ester in embryonal fibroblasts transformed by E1Aad5+cHa-ras-oncogenes by Pospelova, T V, Medvedev, A V, Kisliakova, T V, Svetlikova, S B, Pospelov, V A

“…Regulation of c-fos protooncogene activity in rat embryonal fibroblasts (REF), E1Aad5-immortalized REF cells, and E1Aad5 + cHa-ras transformed REF cells has…”
Get more information

The characteristics of the transformed phenotype and the expression of indicator plasmids in the cells of rat embryonic fibroblasts immortalized by oncogene E1Aad5 and transformed by oncogenes E1Aad5+c-Ha-ras by Pospelova, T V, Kisliakova, T V, Medvedev, A V, Svetlikova, S B, Pospelov, V A

“…Rat embryonal fibroblasts of the second passage have been immortalized or transformed with the E1A region of the human adenovirus type 5 and the cloned…”
Get more information

Functional status of the p53 gene in murine F9 embryonal teratocarcinoma cells by Orlovskaia, E I, Kisliakova, T V, Osipov, K A, Malashicheva, A B, Pospelov, V A

Get more information

Negative control of expression of proto-oncogene c-fos promoter in undifferentiated cells of mouse teratocarcinoma F9 by Kisliakova, T V, Svetlikova, S B, Lavrovskiĭ, Ia V, Pospelova, T V, Pospelov, V A

Get more information